Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocol

BACKGROUND: The prognosis for patients with advanced epithelial ovarian cancer remains poor despite aggressive surgical resection and platinum-based chemotherapy. More than 60% of patients will develop recurrent disease, principally intraperitoneal, and die within 5 years. The use of whole abdominal...

Descripción completa

Detalles Bibliográficos
Autores principales: Rochet, Nathalie, Jensen, Alexandra D, Sterzing, Florian, Munter, Marc W, Eichbaum, Michael H, Schneeweiss, Andreas, Sohn, Christof, Debus, Juergen, Harms, Wolfgang
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212657/
https://www.ncbi.nlm.nih.gov/pubmed/18093313
http://dx.doi.org/10.1186/1471-2407-7-227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212657/
https://www.ncbi.nlm.nih.gov/pubmed/18093313
http://dx.doi.org/10.1186/1471-2407-7-227

Ejemplares similares